Drug factory · FDA FEI 2647548
Messer Gas Puerto Rico Inc
RD 869 KM 1.8 BO, Catano, PR, United States
Problems found, fixed voluntarily at FDA's last inspection, Jul 9, 2015.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
2 drug inspections on record since 2011: 0 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Carbon Dioxide | Makes it | Messer Gas Puerto Rico, Inc | 52374-003, 52374-103 |
| Nitrogen | Makes it | Messer Gas Puerto Rico, Inc | 52374-002, 52374-102 |
| Oxygen | Makes it | Messer Gas Puerto Rico, Inc | 52374-001, 52374-006, 52374-101 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jul 9, 2015 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Dec 22, 2011 | Problems found, fixed voluntarily | Drug Quality Assurance | 6 |
What inspectors wrote down
From FDA's Form 483 citations: conditions an investigator observed that may violate drug manufacturing rules, as FDA published them.
Dec 22, 2011 inspection
- Absence of Written Procedures 21 CFR 211.100(a)
There are no written procedures for production and process controls designed to assure that the drug products have the identity, strength, quality, and purity they purport or are represented to possess. - SOPs not followed / documented 21 CFR 211.100(b)
Written production and process control procedures are not followed in the execution of production and process control functions. - Expiration date lacking 21 CFR 211.137(a)
Drug products do not bear an expiration date determined by appropriate stability data to assure they meet applicable standards of identity, strength, quality and purity at the time of use. - Second person sign off 21 CFR 211.194(a)(8)
Laboratory records do not include the initials or signature of a second person showing that the original records have been reviewed for accuracy, completeness, and compliance with established standards. - Complaint Handling Procedure 21 CFR 211.198(a)
Procedures describing the handling of written and oral complaints related to drug products are deficiently written or followed. - Approve or reject components, products 21 CFR 211.22(a)
The quality control unit lacks the responsibility and authority to approve and reject all drug product containers, closures, in process materials, labeling, and drug products.
Registered with FDA for: manufacture.